Valerio Therapeutics

C4X

Company Profile

  • Business description

    Valerio Therapeutics is a clinical-stage biotechnology company designing and developing novel oncology drugs targeting tumor DNA repair functions. Its therapeutic strategy focuses on fighting tumor resistance to treatments, which poses ever-greater therapeutic challenges, especially in aggressive or rare cancers. its approach is based upon unique mechanisms of action on DNA Damage Response. The company focuses on bringing first-in-class and disruptive compounds from preclinical research to proof-of-concept in man in cancer indications with high unmet needs.

  • Contact

    49 Boulevard du General
    Martial Valin
    Paris75015
    FRA

    T: +33 145587600

    https://www.valeriotx.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    38

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,773.0029.400.34%
CAC 407,665.9125.64-0.33%
DAX 4023,909.61123.61-0.51%
Dow JONES (US)44,094.77275.500.63%
FTSE 1008,760.9637.95-0.43%
HKSE24,072.28211.87-0.87%
NASDAQ20,369.7396.270.47%
Nikkei 22540,487.39336.600.84%
NZX 50 Index12,609.877.050.06%
S&P 5006,204.9531.880.52%
S&P/ASX 2008,542.3028.100.33%
SSE Composite Index3,444.4320.200.59%

Market Movers